Abstract:Detection of circulating tumor cells (CTCs), at the single-cell level, can be of great value for subsequent treatment of tumors but remains a significant challenge. Herein, we report a phage-based detection strategy for the identification of single CTC. The key assay component is the flexible recombinant M13@anti-CEA-scFv probe (M13, CEA, and scFv stand for M13 phage, carcinoembryonic antigen, and single-chain variable region fragment, respectively), which has a high, monoclonal antibody-like binding affinity for tumor cell-expressed CEA antigen, as confirmed by enzyme-linked immunosorbent assay (ELISA). Cell immunofluorescence experiments by confocal microscopy also demonstrate that the M13@anti-CEA-scFv could specifically bind to CEA-positive colon cancer cells such as Caco-2 and HT29, instead of CEA-negative HEK293T cells even when in great excess. Quantitative polymerase chain reaction (qPCR) further proves the ability to pin down single Caco-2 cell in 1 mL of spiked samples by 1,000 copies of M13@anti-CEA-scFv probe, after merely 15 min incubation. Another probe, the rigid magnetic microparticle (MMP), loaded with anti-CEA antibody, is used for the initial screening of the single CTC, which is mixed with numerous lymphocytes. The CEA on the resultant MMPs/CTC complex is subsequently recognized by numerous copies of M13@anti-CEA-scFv to form an MMP/CTC/M13@anti-CEAscFv sandwich complex. Probing the phage DNA in this complex by qPCR leads to the unambiguous identification of the single Caco-2 cell in 1 mL of spiked blood samples. The phage-based detection strategy holds promise for the single-cell detection of any CTCs since the scFv displayed at the end of phage can be customized to the unique antigen of a specific CTC. (c) 2021 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

Identification of Tumor Associated Single-Chain Fv by Panning and Screening Antibody Phage Library Using Tumor Cells

[Production of phage-displayed single chain variable fragments of monoclonal antibody MGb1].

Cell-based Screening of Phage Antibody Library

Isolation and Identification of Specific Single Chain Antibodies Against Cell Surface Molecules

Identification of New Antibodies Targeting Malignant Plasma Cells for Immunotherapy by Next-Generation Sequencing-Assisted Phage Display

Bioscreening of Phage Display Antibody Library and Expression of A Humanized Single-Chain Variable Fragment Antibody Against Human Connective Tissue Growth Factor (Ctgf/ccn2)

Identification of Single Chain Antibodies to Breast Cancer Stem Cells Using Phage Display

Combining Fluorescent Cell Sorting and Single B Cell Amplification to Screen the Monoclonal Antibody Gene against Human Glypican-1 in Pancreatic Cancer

High Efficiency Reconstitution of a Human–Mouse Chimeric Fab of CAb‐1 Antibody Specific to Human Colon Cancer

Semi-Automated Cell Panning for Efficient Isolation of FGFR3-Targeting Antibody

Phage antibody library screening for the selection of novel high-affinity human single-chain variable fragment against gastrin receptor: an in silico and in vitro study

Construction and Screening of Phage Antibody Libraries Against Epidermal Growth Factor Receptor Variant Type Ⅲ

Screening of scFvs against cTnI from Phage Display Antibody Library and Their Expression in E.coli Rosetta

Screening of Scfvs Against Ctni from Phage Display Antibody Library and Their Expression in E. Coli Rosetta

Discovery of a fully human antibody to the proximal membrane terminus of MUC1 based on a B-cell high-throughput screening technique

Construction of Phage Antibody Library Associated with Multidrug Resistance in Carcinoma Cells

scFv-Based “Grababody” as a General Strategy to Improve Recruitment of Immune Effector Cells to Antibody-Targeted Tumors

Screening Tumor-Targeting Bacteriophage Particles by Pre-Clearing Phage Display

Generating improved single-chain Fv molecules for tumor targeting

[Phage antibody library technology in tumor therapy: a review].

Detection of a Single Circulating Tumor Cell Using a Genetically Engineered Antibody-Like Phage Nanofiber Probe